The Union health ministry amended substituting cell or stem derived product to be defined as "new drug" under WCTR 2019 or New Drugs, and Clinical Trials Rules 2019. It is for efficient clarity and amenability of such drugs derived using stem cell technologies. This move has been taken considering the term "cell-derived product" is missing in the New Drug definition under NDCT rules that only involves stem cell-derived products. On February 9, 2021, the central government, through a letter, has given directions as per 33P to all main health secretaries of the States and Union Territories for issuing clarification on stem cell-derived products as per NDCT Rules 2019. The given directions also clarify that all cell-based things are concealed in NDCT rules as per various criteria present in the letter. All these are based on the commendations of the 84th DTAB in a meeting held on August 27, 2019, and 85th DTAB held on July 29, 2020. It is also relevant to present...
Expert tips Latest Breaking News, Pictures, Videos, and Special Reports from The News and Tips Expert. Get the expert tips from the Blogs, Comments and Archive News on Newsandtipsexpert.blogspot.com